News Archive of BioSpace - Breaking News

ArticleAdded
Enanta Pharmaceuticals, Inc. Announces Grants Positive Opinion For An Eight-Week Treatment Option With AbbVie??'s VIEKIRAX(Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) For Patients With Genotype 1b Chronic Hepatitis C 02-27-17
Sunovion Announces Positive Topline Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression 02-27-17
La Jolla Pharma Announces Positive Top-Line Results From ATHOS-3 Phase 3 Study Of LJPC-501 02-27-17
Meet the Woman Developing the Next Generation of Insulin at Novo Nordisk A/S 02-27-17
Seattle's CTI BioPharma Names a New CEO 02-27-17
Endo Pharma Issues Voluntary Nationwide Recall For One Lot Of Edex (Alprostadil For Injection) 10 Mcg 2 Pack Carton Due To Potential Lack Of Sterility Assurance 02-27-17
This One Small-Cap Biotech Could Make You Rich 02-27-17
Bracco Diagnostics Receives U.S. FDA Approval For VARIBAR PUDDING (Barium Sulfate) Oral Paste For Fluoroscopy 02-27-17
GlaxoSmithKline to Shut Down Costa Rica Plant, 150 Jobs Affected 02-27-17
Advaxis, SELLAS Life Sci Ink $358 Million Cancer Immunotherapy R&D Pact 02-27-17
Full Data On Baxter International??'s Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease 04-17-15
4SC Pockets €95 Million Upfront From Resminostat Deal With Menarini Asia-Pacific Group (Formerly Invida Group) 04-17-15
PharMerica Announces First Quarter 2015 Earnings Call And Webcast 04-17-15
Amerigen Pharmaceuticals Announces Tentative Approval Of Generic Bystolic 04-17-15
Ariad Presents Updated Clinical Data On Brigatinib In Patients With ALK+ Non-Small Cell Lung Cancer 04-17-15
Anika Therapeutics Reports On Cingal 13-01 Study Clinical Trial Top Line Data And Announces The Completion Of Cingal 13-02 Study??'s Patient Enrollment 04-17-15
Full-Service CRO CTI - Clinical Trial and Consulting Services Broadens Use Of Medidata Solutions, Inc. Technology Platform For More Efficient, Higher Quality Clinical Trials 04-17-15
Burzynski Research Institute Announces Publication Of Phase II Results In Patients With Non-Diffuse Intrinsic Pontine Glioma 04-17-15
Harvard Apparatus Regenerative Technology CEO Resigns 04-17-15
H. Lundbeck A/S and Otsuka America Pharmaceutical, Inc. Release: Results Of Phase III Study Of Brexpiprazole In Adult Patients With Schizophrenia Published In /i> 04-17-15
MedDay Announces Its Pivotal Phase III Study Of MD1003 In Patients With Progressive Multiple Sclerosis Meets Primary Endpoint 04-17-15
Emotional Brain Obtains Patent Extension For Its Female Sexual Dysfunction Medication 04-17-15
Athersys, Inc. Craters as Stem Cell Therapy Fails Phase II Stroke Study 04-17-15
RXi Pharmaceuticals Receives Orphan Drug Designation For Samcyprone From The U.S. FDA For The Treatment Of Malignant Melanoma Stage IIb to IV 04-17-15
Bionomics Limited Showcases Oncology Drug Development Programs At 2015 American Association for Cancer Research Annual Meeting 04-17-15
Athersys, Inc. Announces Results From Phase 2 Study Of Multistem Cell Therapy For Treatment Of Ischemic Stroke 04-17-15
AstraZeneca PLC's Experimental Lung Cancer Drug Delays Disease By More Than a Year 04-17-15
Oncolytics Biotech Inc. Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Malignant Gliomas 04-17-15
Children's Hospital of Philadelphia Release: Restoring Cellular Energy Signals May Offer Promise Of Treating Mitochondrial Diseases In Humans 04-17-15
Mallinckrodt Completes Acquisition Of Ikaria 04-17-15
CIRA And Takeda Enter 10-Year Collaboration On iPS Cell Research 04-17-15
Novogen Limited And Feinstein Institute Join Forces To Find Effective Treatments For Brain Cancer 04-17-15
Perrigo Company Announces The Launch Of A Generic Version Of Kenalog Nasal Spray 04-17-15
Sigma-Aldrich Corporation Expands Customer-Centric Model With Investments In Singapore That Localize World-Class Capabilities To Better Support Customers In Asia 04-17-15
Centene Corporation Release: Receives Full Accreditation 04-17-15
Amgen Announces Webcast Of 2015 First Quarter Financial Results 04-17-15
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $14 Million Research Expansion With Genzyme 04-16-15
KemPharm Announces Pricing Of IPO 04-16-15
H. Lundbeck A/S And Ovid Technologies Announce Exclusive Worldwide Licensing Agreement For Gaboxadol 04-16-15
PsiOxus Therapeutics Limited Expands Clinical Studies For Immuno-Oncolytic Treatment Following Positive Response To Intravenous Delivery 04-16-15
Momenta Pharmaceuticals, Inc. Announces FDA Approval Of ANDA For Glatopa (Glatiramer Acetate Injection), The First Substitutable Generic For COPAXONE (Glatiramer Acetate Injection) 20mg 04-16-15
Targacept Announces Negative Top-Line Results From Exploratory Study Of TC-6499 In Diabetic Gastroparesis 04-16-15
Enanta Pharmaceuticals, Inc. Announces AbbVie??'s Investigational Treatment Regimen For Genotype 1 Chronic Hepatitis C Granted Priority Review In Japan 04-16-15
FDA Advisory Committee Recommends Approval Of The Medicines Company's Antiplatelet Therapy Cangrelor 04-16-15
Baxter International Submits Application To Japan??'s MHLW For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A 04-16-15
Relmada Therapeutics Receives Health Canada Clearance to Further Explore Promising NMDA Receptor Antagonist d-Methadone (REL-1017) 04-16-15
Health Canada Approves New Indication For The Use Of Xtandi (enzalutamide) Capsules For Patients With Metastatic Castration-Resistant Prostate Cancer 04-16-15
Baxter International Submits Application To Japan's For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A 04-16-15
AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review In Japan 04-16-15
Adamis Pharmaceuticals Announces Positive Clinical Study Results For Its Albuterol (Salbutamol) HFA Product 04-16-15
RegeneRx JV Retains Ora, Inc. To Conduct Phase 3 Trial For NK And Phase 2b/3 Trial For Dry Eye Syndrome In U.S. 04-16-15
DelMar Pharmaceuticals Adds Fourth Clinical Trial Site In Phase I/II Multicenter Study Of VAL-083 For Recurrent Malignant Glioma 04-16-15
Amgen Nabs Long-Awaited FDA Approval of Heart Failure Drug Corlanor 04-16-15
The Medicines Company Surges as FDA Panel Approves Once-Rejected lood Clot Preventer 04-16-15
FDA Advisory Committee Recommends Approval Of The Medicines Company's Antiplatelet Therapy Cangrelor 04-16-15
Amgen Release: FDA Approves Corlanor (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure 04-16-15
Repros Therapeutics Inc. Announces November 30, 2015 PDUFA Goal Date For New Drug Application 04-16-15
Galena Biopharma Completes Over-Enrollment Of Neuvax (Nelipepimut-S) Phase 3 PRESENT Clinical Trial 04-16-15
ZS Pharma Announces Publications In Peer-Reviewed Medical Journals 04-16-15
Cellectar Biosciences Initiates Proof-Of-Concept Trial Of I-131-CLR1404 In Multiple Myeloma 04-16-15
U.S. Patent Office Declares An Interference Between Forward Pharma And Biogen Regarding The Treatment Of Multiple Sclerosis With 480 Mg Daily Dose Of DMF, The Active Ingredient In Tecfidera 04-16-15
XBiotech USA, Inc. Announces Pricing Of Initial Public Offering 04-16-15
BioMarin To Host First Quarter 2015 Financial Results Conference Call And Webcast On Thursday, April 30 At 4:30pm ET 04-16-15
IntelliPharmaCeutics Announces First Quarter 2015 Results 04-16-15
Pacific Biosciences First Quarter 2015 Financial Results Call 04-16-15
PharmaCyte Biotech Appoints Former Pfizer And Alchemia Executive To Board Of Directors 04-16-15
NewLink Genetics And Merck & Co. Receive Vaccine Industry Excellence Awards At 04-16-15
Amphastar Pharmaceuticals, Inc. To Present At The 14th Annual Healthcare Conference 04-16-15
G1 Therapeutics To Present New Data On CDK4/6 Inhibitor G1T28 At The American Association for Cancer Research Annual Meeting 04-16-15
Curis, Inc. Announces Presentation Of Data From CUDC-427 And IRAK-4 Programs At American Association for Cancer Research Annual Meeting 04-16-15
Peregrine Pharmaceuticals, Inc. Announces Three Abstracts Accepted For Presentation At American Association for Cancer Research 2015 Annual Meeting 04-16-15
Catalyst Pharmaceuticals Announces Oral Presentation Of Firdapse Phase 3 Trial Data At American Academy of Neurology Annual Meeting 04-16-15
Replicel Life Sciences Receives Approval To Conduct Clinical Trial For Patients With Chronic Achilles Tendinosis 04-15-15
Phase III Trial Of The Merck & Co. And NewLink Genetics Investigational Ebola Vaccine Initiated In Sierra Leone 04-15-15
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair 04-15-15
CytoTools: Recruitment Of Patients Now Complete For European Studies On Diabetic Foot (DFU) And Ulcus Cruris (VLU) Indications 04-15-15
Oncobiologics Inc. Announces Completion Of Clinical Dosing For bevacizumab (Avastin biosimilar) Candidate 04-15-15
Arcadia Biosciences Release: Study Shows Nitrogen Use Efficiency Trait Increases Biomass Of Sugarcane 04-15-15
Pfizer Announces Paloma-3 Trial For Ibrance?? (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With Hr+, Her2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy 04-15-15
Cellectis Plant Sciences, Inc. Publishes A Study Demonstrating Reduced Acrylamide In Fried Potatoes 04-15-15
Celsion Corporation Announces Positive Interim Data From Its Phase 2 DIGNITY Study In Breast Cancer 04-15-15
Biothera Immunotherapy Combination Results In Tumor Reduction During Maintenance Phase Of Non-Small Cell Lung Cancer Study 04-15-15
Study Published In Shows INVEGA SUSTENNA Effective Six Months Longer Than Common Oral Antipsychotics In Treatment Of Schizophrenia 04-15-15
SELLAS Life Sciences Group And Trojantec Ltd. Sign Exclusive License Agreement For Global Rights On Development And Commercialization Of Innovative TR-1 Anti-Cancer Antennapedia Technology 04-15-15
Ophthalmology-Focused CROs, Iris Pharma And Announce Strategic Alliance To Offer International Specialized Services To The Ophthalmic Market 04-15-15
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 04-15-15
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 04-15-15
Is Johnson & Johnson Eyeing Large M&As? 04-15-15
FDA Advisory Committee Reviews Takeda's Alogliptin Examine Cardiovascular Safety Outcomes Trial 04-15-15
Study Published In The /i> Identifies The First Genetic Variant Directly Correlated To Mitotic-Origin Aneuploidy In Human Embryos 04-15-15
Coherus And Baxter International Announce Amendment To Etanercept Biosimilar Collaboration Agreement 04-15-15
Heart Metabolics Limited And FDA Reach Agreement On Special Protocol Assessment For Single Phase 3 Trial Of Perhexiline In Hypertrophic Cardiomyopathy 04-15-15
Cidara Therapeutics Announces Pricing Of IPO 04-15-15
Foamix Pharmaceuticals, Ltd. Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 04-15-15
Cord Blood Banking Leader Cryo-Cell International Reports Fiscal First Quarter 2015 Financial Results 04-15-15
Momenta Pharmaceuticals, Inc. Announces Date Of First Quarter 2015 Financial Results Conference Call And Webcast 04-15-15
Adamis Announces Key Additions To Its Commercial Sales Team 04-15-15
Celgene Elects To Its Board Of Directors 04-15-15
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair 04-15-15
Simulations Plus Reports Second Quarter FY2015 Financial Results 04-15-15
Simulations Plus Second Quarter FY2015 Financial Results 04-15-15
IOmet Pharma Announces The Appointment Of Rakesh Patel As A Non-Executive Director 04-15-15
American Academy of Neurology Release: Experimental Drug That May Repair Nerve Damage In MS Moves Forward 04-15-15
Envisia Therapeutics To Present At The Ophthalmology Innovation Summit 04-15-15
Jounce Therapeutics To Present At The 04-15-15
Navidea Biopharmaceuticals Announces Lymphoseek Presentations At Upcoming Medical Conferences 04-15-15
Cerulean Pharma Inc. To Present At 14th Annual Healthcare Conference 04-15-15
Macrophage Therapeutics Announces Manocept Results In Kaposi??'s Sarcoma Studies To Be Presented At The American Association for Cancer Research 04-15-15
Asana Biosciences To Present Preclinical Data For A Novel Dual Inhibitor Of SYK And JAK Family Kinases And A 5T4-Targeted Antibody Drug Conjugate At The American Association for Cancer Research Annual Meeting In Philadelphia, April 18-22, 2015 04-15-15
FDA Panel Wants Heart Risk Warnings for AstraZeneca PLC's Onglyza and AstraZeneca PLC's Nesina 04-15-15
Bayer AG's Devises Phase III Plans for Top Prospect 04-14-15
pSivida Corp Reports ILUVIEN For DME Approved In Poland 04-14-15
Hydra Biosciences, Inc. Receives Approval From Health Canada To Begin Phase 1 Trial For HX-100 04-14-15
Teva And Eagle Pharmaceuticals Announce NDA For Bendamustine Rapid Infusion Product Accepted For Filing 04-14-15
Puma Biotechnology Expands Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients 04-14-15
Pressure BioSciences, Inc. To Collaborate With On Improving And Extending The Use Of s PCT Platform For The Detection Of DNA In Forensic Samples 04-14-15
BioReference Laboratories, Inc. Partners With Organizations Accelerating Medical Innovation 04-14-15
Roche Grabs a "Liquid Biopsy" Startup Targeting Cancer 04-14-15
Takeda Brings in Ex-Eli Lilly Exec to Lead U.S. Business Unit 04-14-15
Alimera Sciences' ILUVIEN Receives 17th European Marketing Authorization; Completing Second Wave Of Country Approvals 04-14-15
Soligenix Announces FDA Protocol Clearance Of Pivotal Phase 3 Clinical Trial Of SGX203 In Pediatric Crohn's Disease 04-14-15
Pharmalink AB Announces Positive Result In Phase 2b Trial Of Nefecon 04-14-15
C-FDA Approves IND For D-Pharm Ltd.'s Anti-Epileptic Drug, DP-VPA In China 04-14-15
IBM Corporation & Apple Expand Partnership To Help Transform Medical Research 04-14-15
Actavis And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-releasing intrauterine system) 52 Mg To Prevent Pregnancy For Up To Three Years 04-14-15
Mylan Settles Patent Litigation Related To Viagra 04-14-15
Vanda Pharmaceuticals, Inc. Announces Trial Date For Fanapt Patent Cases 04-14-15
Concordia Healthcare Announces Upsizing And Pricing Of Senior Notes Offering 04-14-15
Prime Therapeutics Names President And CEO 04-14-15
IBM Corporation Joins Apple, Johnson & Johnson, Medtronic to Analyze Health Data in the Cloud 04-14-15
Accovion Signs Agreement To Be Acquired By Clinipace Worldwide 04-13-15
Renova Therapeutics Recruits Seasoned Expert To Lead Company's Regulatory And Quality Efforts 04-13-15
Onxeo Announces 6th Positive DSMB Recommendation For Livatag Relive Study In HCC 04-13-15
ARCA biopharma Receives FDA Fast Track Designation For Gencaro Atrial Fibrillation Development In A Genetically Targeted Heart Failure Population 04-13-15
Arrowhead Research Corporation Cleared To Proceed With Multiple Dose Phase 2b Study Of ARC-520 04-13-15
UK??'s Joins CEL-SCI??'s Phase III Head And Neck Cancer Trial 04-13-15
Cytori Therapeutics, Inc. Provides Twelve Month Data Update On Scleradec-I Trial 04-13-15
Suven Life Sciences Ltd Initiated Multiple Ascending Dose (MAD) Studies In Phase 1 Clinical Trial For Their Investigational Compound SUVN-G3031 04-13-15
Allergan, Valeant and Finally End Fight Over Failed Buyout 04-13-15
Depomed, Inc. Announces Gralise ANDA Litigation Settlement Confirming Exclusivity To 2024 And Dismissing Appeal 04-13-15
AEterna Zentaris Announces Plans To Initiate Phase 3 Study Of Macrilen In AGHD Following Successful Meeting With FDA 04-13-15
Neothetics Initiates Pivotal Phase 3 Clinical Trials For LIPO-202, The First Non-Invasive Injectable Drug Candidate For Reduction Of Subcutaneous Abdominal Fat 04-13-15
Mechanism Of Action Of ABIVAX's First-in-class Anti-HIV Drug Published Today In Peer-Reviewed Journal Retrovirology 04-13-15
Versartis, Inc. Initiates Phase 2/3 Trial Of VRS-317 In Japan For Children With Growth Hormone Deficiency 04-13-15
InnFocus FDA Phase One Enrollment Reaches 75 Patient Filing Milestone 04-13-15
Upsher-Smith Laboratories To Present Data Evaluating The Long-Term Safety And Efficacy Of Qudexy XR (Topiramate) Extended-Release Capsules And Alternative Administration Techniques 04-13-15
ZeaVision, LLC Release: Clinical Research Study Demonstrates EyePromise EZ Tears Relieves Dry Eye Symptoms And Discomfort Fast 04-13-15
Milo Biotechnology Release: First Duchenne Muscular Dystrophy Patient Treated In Follistatin Gene Therapy Trial 04-13-15
Qualyst Transporter Solutions Highlights New Perspective On Intracellular Concentrations As Critical In Designing In Vitro Studies 04-13-15
Ranbaxy Pharmaceuticals Canada Release: Recall Of One Batch Of RAN-Gabapentin 100 Mg Capsules Due To Cross-Contamination With Etodolac 04-10-15
Shire Release: FDA Grants Priority Review To Lifitegrast NDA For The Treatment Of Dry Eye Disease In Adults 04-10-15
Eisai Company And Arena Pharmaceuticals, Inc. Complete Registrational Trials Of An Extended Release Formulation Of Lorcaserin 04-10-15
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Shows That Health-Related Quality-Of-Life Is Higher In ABSSSI Patients Deemed Cured Vs Improved After End Of Treatment 04-10-15
Cesca Therapeutics Management Provides Update On Clinical Trials For Critical Limb Ischemia ("CLI") And Acute Myocardial Infarction ("AMI") 04-10-15
Adamas Pharmaceuticals Receives Orphan Drug Designation For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia Associated With Parkinson's Disease 04-10-15
Horizon Pharma Receives FDA Fast Track Designation For ACTIMMUNE In The Treatment Of Friedreich's Ataxia 04-10-15
Admedus Herpes Phase II ??? First Dosing To Commence 04-10-15
FDA Modifies Partial Clinical Hold On Tekmira's TKM-Ebola IND To Allow Multiple Dosing Of Healthy Volunteers 04-10-15
Sihuan Pharmaceutical Starts US Trial Of Novel Cancer Drug 04-10-15
ChromaDex, Inc. Release: Published Study Shows Topical Treatment With Pterostilbene Effectively Protects Hairless Mice Against UVB Radiation-Induced Skin Damage And Carcinogenesis 04-10-15
New Research Shows PharmaCyte Biotech's Melligen Cell Line Can Reverse Diabetes 04-10-15
REVOLUTION Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson To Board Of Directors 04-09-15
Distraught Eisai Company Chops About 450 U.S. Jobs 04-10-15
Ceres, Inc. Announces One-For-Eight Reverse Stock Split 04-09-15
Onxeo Release: Belinostat Phase I/II Results In Soft Tissue Sarcoma To Be Presented At The 2015 Annual Meeting 04-09-15
MPN Genetics Network Release: CRISPR Researchers Target Incurable Blood Cancer 04-09-15
Anika Therapeutics Files IDE Application With U.S. FDA For Hyalofast 04-09-15
Pharmacyclics Release: New Longer-Term IMBRUVICA (ibrutinib) Data Show High Response Rates In Patients With Waldenstrom's Macroglobulinemia 04-09-15
Novogen Limited Release: Australian Studies Confirm Anisina As Potential Important New Weapon Against Melanoma 04-09-15
VBI Vaccines Announces New Data Supporting The Manufacture Of Its Prophylactic CMV Vaccine Candidate 04-09-15
BioLife Solutions, Inc. CryoStor Cell Preservation Media Embedded In Cardio3 BioSciences' Phase III Clinical Trials Of C-Cure Cell Therapy For Congestive Heart Failure 04-09-15
Exelixis, Inc.??'s Cabozantinib Granted Fast Track Designation By FDA For Advanced Renal Cell Carcinoma 04-09-15
Recro Pharma Announces Update On On-Going Phase II Clinical Trial Of Dex-IN For Treatment Of Acute Pain On Day 1 Following Surgery 04-09-15
Dermira Doses First Patient In DRM01 Phase IIb Acne Trial 04-09-15
BioBlast Pharma Announces Granting Of Fast Track Designation By The FDA For Cabaletta In Oculopharyngeal Muscular Dystrophy (OPMD) 04-09-15
Shire Reports Topline Results From First Of Three Placebo-Controlled Phase 2 Studies Of SHP625 (LUM001) In Children With Alagille Syndrome 04-09-15
MedImmune Release: MEDI8897 Receives Fast Track Designation By The FDA For The Prevention Of Respiratory Disease Caused By RSV In Infants 04-09-15
Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses In Head & Neck Cancer Patients 04-09-15
Neurotrope Receives FDA Orphan Drug Designation For Bryostatin In The Treatment Of Fragile X Syndrome 04-09-15
Profectus BioSciences, Inc.' Ebola Vaccine Shown Effective And Safe In Providing Rapid, Single-Dose Protection Against Current "Makona" Ebola Outbreak Strain In Non-Human Primates 04-09-15
Mylan Proposes To Acquire Perrigo Company For $205 Per Share 04-09-15
TRACON Pharmaceuticals, Inc. Expands License Agreement And Signs Research Agreement With Case Western Reserve University 04-09-15
NeoStem, Inc. Announces Extension Of Study Under Grant From To Fund Research Of Retinal Disease 04-09-15
Trillium Therapeutics Inc. Announces Completion Of Public Offering Of Securities 04-08-15
Dr. Reddy's Laboratories Ltd. And Its Subsidiary Promius Pharma, LLC Announce The Filing Of Three NDAs With The 04-08-15
Gilead Submits New Drug Application To U.S.FDA For Fixed-Dose Combination Of Emtricitabine/Tenofovir Alafenamide For HIV Treatment 04-08-15
Prolong Pharmaceuticals' Flagship Product SANGUINATE Granted Orphan Drug Designation By The FDA 04-08-15
DiscoveryBioMed Is Awarded A New Phase II SBIR Grant Award To Develop New Medicines To Fight The Diabetes And Obesity Epidemic In The U.S. And Globally 04-08-15
Rhythm Initiates Phase 2b Clinical Trial Of Relamorelin For Diabetic Gastroparesis 04-08-15
EU Approves Roche??'s Avastin Plus Chemotherapy For Women With Advanced Cervical Cancer 04-08-15
ANI Pharmaceuticals, Inc. Presents At 14th Annual Healthcare Conference 04-08-15
Endocyte, Inc. Appoints As Vice President Of Imaging 04-08-15
Perrigo Company Announces FDA Approval And Upcoming Launch Of The AB Therapeutic Equivalent To Exalgo 04-08-15
Mesoblast Limited Phase 3 Program For Degenerative Disc Disease To Include European Sites After Positive Meeting With European Medicines Agency 04-08-15
Portola Pharmaceuticals, Inc. Announces New Topline Data From Phase III Annexa-A Trial Part 2: Breakthrough Designated Andexanet Alfa 04-08-15
Capricor Therapeutics, Inc. Completes Enrollment Of Initial Phase Of DYNAMIC Clinical Trial Of Cardiosphere-Derived Cell Therapy For Treatment Of Advanced Heart Failure 04-08-15
Advaxis, Inc. And Merck & Co. Announce Initiation Of Enrollment In The Phase I/II Study Of ADXS-PSA In Combination With Anti-PD-1 Therapy, KEYTRUDA (Pembrolizumab), For The Treatment Of Advanced Prostate Cancer 04-08-15
First Reported Case Of Six-Year Survival For Patient With Metastatic Lung Cancer And Rare Genetic Mutation: /i> Reveals 04-08-15
Lion Biotechnologies, Inc. Announces Publication Of Data From Clinical Study Of Metastatic Cervical Cancer Patients Treated With HPV-TIL 04-08-15
STEM CELLS Translational Medicine Release: Study Showing How Stem Cells Slow Aging May Lead To New Heart Failure Treatments 04-08-15
Novel Painkiller With Little Or No Signs Of Addiction And Other Serious Opioid Side Effects Patented By Phoenix PharmaLabs, Inc. 04-08-15
Inovio Pharmaceuticals Selected By Defense Advanced Research Projects Agency To Lead A $45 Million Program To Expedite Development Of Novel Products To Prevent And Treat Disease Caused By Ebola 04-08-15
ArmaGen Technologies, Inc. Announces FDA Acceptance Of IND Application For AGT-181 For The Treatment Of Hurler Syndrome 04-08-15
Rhythm Initiates Phase 2b Clinical Trial Of Relamorelin For Diabetic Gastroparesis 04-08-15
Egalet Announces Closing Of $60 Million Offering of Convertible Senior Notes Due 2020 04-08-15
Relmada Therapeutics Appoints As Senior Vice President Of Business Development 04-08-15
Alzheon Banks $10 Million to Take Scrapped Alzheimer's Drug to Trial; CEO Claims Has the Goods to Beat Biogen 04-08-15
Gilead's Next-Gen HIV Drug Heads to the FDA 04-08-15
Gilead Submits New Drug Application To FDA For Fixed-Dose Combination Of Emtricitabine/Tenofovir Alafenamide For HIV Treatment 04-08-15
Ferring Pharmaceuticals Announces European Approval Of New Room Temperature Stable Formulation Of PABAL (Carbetocin) 04-07-15
Cytori Therapeutics, Inc. Granted Orphan Drug Status For Cellular Therapeutic In European Union 04-07-15
Cytori Therapeutics, Inc. Granted Orphan Drug Status For Cellular Therapeutic In European Union 04-07-15
GlycoMimetics, Inc. Provides Update On Pfizer??'s Plans To Initiate Phase 3 Trial With Rivipansel In Mid-2015 04-07-15
Ocular Therapeutix Reports Topline Clinical Data For Its Second Phase III Clinical Trial Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 04-07-15
Repros Therapeutics Inc. Receives Confirmation Of Eligibility For Submission Of A Centralized Marketing Authorization Application To The European Medicines Agency As A New Active Substance 04-07-15
Anavex Encouraged By New Scientific Data Revealing Positive Role Of Sigma-1 Receptors In Brain Injuries 04-07-15
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur To Enhance Vaccine Stability 04-07-15
Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories Ltd. To Co-Develop, Market & Sell Generx Angiogenic Microvascular Gene Therapy In Certain International Markets 04-07-15
Ocular Therapeutix Stock Caves as Eye Pain Drug Flops Pivotal Trial 04-07-15
Oncolytics Biotech Inc. Announces Filing For Orphan Drug Designation With The U.S. FDA For Gastric Cancer 04-07-15
Ocular Therapeutix Reports Topline Clinical Data For Its Second Phase 3 Clinical Trial Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 04-07-15
Benitec, Inc. Provides Update On TT-034 Trial 04-07-15
YPrime Awarded Global Phase II Oncology Clinical Trial Which Will Utilize Proprietary eClinical Supply Forecasting Tool Combined With IRT 04-07-15
Celldex' Phase 2 EMERGE Study Of Glembatumumab Vedotin In Metastatic Breast Cancer Published In /i> 04-07-15
Progenics Pharmaceuticals, Inc. Announces The Initiation Of Fuji's Phase 2 Trial For 1404 In Japan 04-07-15
Caris Life Sciences And Enter Collaboration To Measure Clinical And Economic Impact Of Evidenced-Based Drug Selection For Precision Medicine In Oncology 04-07-15
Resverlogix Corporation Receives Two Patents For RVX-208 In China 04-07-15
Mylan Launches First Generic Version Of Generess Fe 04-07-15
VisiVite Launches AREDS2 E-Free Blue Formula: Macular Support For Those On Anticoagulant Therapies 04-07-15
Arena Pharmaceuticals, Inc. Receives Additional Patent For BELVIQ (lorcaserin HCl) From United States Patent And Trademark Office 04-07-15
SAFC Launches New EX-CELL Advanced Products For Scalable, Efficient Biopharmaceutical Manufacturing 04-07-15
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 04-07-15
Merck & Co. Gambles $434 Million on Arvinas' Protein Disposal System 04-07-15
Nabriva Therapeutics Wraps Up $120 Million Financing Round 04-07-15
Rumors Prove True as SoCal's aTyr Pharma Files for $86 Million IPO 04-07-15
UK National Graphene Institute Selects Bruker Corporation As Official Partner 04-06-15
RestorGenex Reports Corporate Highlights And Financial Results For 2014 04-06-15
Ariad Announces Approval Of Iclusig (As Ponatinib Hydrochloride) In Canada 04-06-15
Actavis Confirms Generic Letairis Patent Challenge 04-06-15
Icon Bioscience Reports Successful Outcomes Of Phase 3 Study Of IBI-10090, A Novel Sustained Release Drug Being Developed To Treat Inflammation Associated With Cataract Surgery 04-06-15
Alkermes Announces Positive Topline Results From Complete Six-Month Phase 2 Clinical Trial Of ALKS 3831 In Schizophrenia 04-06-15
Alcobra To Present At Two CNS Focused Conferences In April 04-06-15
European Commission (EC) Approves Amgen's Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer 04-06-15
FDA Files Supplemental New Drug Application for Boehringer Ingelheim's Pradaxa (dabigatran etexilate mesylate) For The Prophylaxis Of Deep Venous Thrombosis And Pulmonary Embolism After Hip Replacement Surgery 04-06-15
Celldex Announces Initiation Of Phase 1/2 Study Of Varlilumab In Combination With Ipilimumab And CDX-1401 In Metastatic Melanoma 04-06-15
Curis, Inc. Announces Orphan Drug Designation For CUDC-907 In Diffuse Large B-Cell Lymphoma 04-06-15
Immunomedics, Inc. To Provide Update On Sacituzumab Govitecan For The Therapy Of Solid Cancers 04-06-15
Regen BioPharma CEO Discusses Recent Financings, New Laboratory Facilities And Preferred Stock Dividend 04-03-15
Kite Pharma Announces Publication In /i> Articles Authored By Lead Collaborators At The National Cancer Institute And The Netherlands Cancer Institute (NCI) 04-06-15
Advaxis, Inc. And To Collaborate On Pivotal Phase 2/3 Clinical Trial Of ADXS-HPV In Anal Cancer 04-06-15
CAPNIA, Inc. Awarded NIH Grant To Develop Sickle Cell Anemia Screening In Developing Countries 04-06-15
Taubman Institute Receives $3 Million Wexner Gift To Support Emerging Physician-Researchers 04-06-15
Mallinckrodt Launches Notes Offering 04-06-15
Charleston Laboratories, Inc. Completes Patient Enrollment In A Phase 3 Study Of Lead Product, CL-108 04-06-15
Neurotrope Selects Worldwide Clinical Trials To Commence Services For Phase 2B Trial Of Bryostatin For The Treatment Of Alzheimer's Disease 04-06-15
Replicor Announces Completion Of Enrollment In Phase II Trial 04-03-15
BIND Therapeutics Announces Extension Of Global Collaboration With Pfizer To Develop And Commercialize Multiple Accurins 04-03-15
Federal Grant Awarded To The University of Minnesota To Study The Efficacy Of Remote Monitoring In Alzheimer's Care 04-03-15
Hi-Tech Pharmaceuticals Announces Thermo-Rx Brand Acacia Rigidula Extract Clinical Study Results 04-03-15
MD Anderson Cancer Center, Astellas Pharma Inc. Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 04-03-15
Supernus Pharmaceuticals Announces Issuance Of Sixth U.S. Patent Protecting Trokendi XR 04-03-15
ImmuDyne, Inc. Progress Report 04-03-15
IntelGenx Corp. Grants Stock Options 04-03-15
CDC Release: Multidrug-Resistant Shigellosis Spreading In The United States 04-03-15
OXiGENE Announces Participation In Upcoming Investor And Medical Conferences 04-03-15
VIVUS, Inc. to Trim U.S. Salesforce By a Third 04-03-15
Bay Area's Banks $350 Million to Back Daring Life Science Entrepreneurs With a Futuristic Vision 04-03-15
Depomed, Inc. Announces Closing Of Acquisition Of U.S. Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended Release Tablets And NUCYNTA (tapentadol) Oral Solution From For $1.05 Billion 04-03-15
Radlink Announces Exclusive Sales Agency Agreement With Johnson & Johnson Subsidiary DePuy Synthes Companies 04-03-15
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary On New Third Board In China 04-03-15
Janssen Pharmaceuticals, Inc. Completes Divestiture Of U.S. License Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended-Release Tablets And NUCYNTA (tapentadol) Oral Solution To Depomed, Inc. 04-03-15
Aptuit To Expand API Capacity Due To Increased Demand For Integrated Development 04-03-15
AMRI to Shutter UK Facility and Lay Off 62 Workers 04-03-15
Heron Therapeutics, Inc. Reaches Target Patient Enrollment In MAGIC Phase 3 Study Of SUSTOL 04-02-15
Nektar Therapeutics Announces Receipt Of $100 Million Milestone Payment From AstraZeneca PLC 04-02-15
NYU Langone Medical Center Release: Key Mechanism Identified In Pediatric Bone Cancers That Allows Proliferation Of Tumor-Forming Stem Cells 04-02-15
Coronado Biosciences Forms New Subsidiary, To Develop Novel Immunotherapies For Cytomegalovirus 04-02-15
Repros Therapeutics Inc. Announces Acceptance For Filing Of NDA 04-02-15
Astellas Pharma Inc. Release: Enzalutamide Demonstrates Statistically Significant Improvement In Progression Free Survival Compared With Bicalutamide In Strive Trial 04-02-15
Ocera Therapeutics, Inc. Completes Interim Analysis Of OCR-002 In Phase 2b STOP-HE Study For The Treatment Of Acute Hepatic Encephalopathy 04-02-15
SAGE Therapeutics Announces Positive End-Of-Phase 2 Meeting With FDA And Planned Initiation Of SAGE-547 Global Phase 3 Trial In Mid-2015 04-02-15
Teva And Xenon Pharmaceuticals Inc. Announce Enrollment Of First Patient In A Phase 2b Study Evaluating TV-45070 For Postherpetic Neuralgia (PHN) 04-02-15
Intrexon Corporation Signs With The National Cancer Institute For RheoSwitch Controlled IL-12 Cancer Therapies Using T Cell Receptors (TCR) Derived From Peripheral Blood 04-02-15
BioLight Announces Strategic Partnership To Significantly Expand Presence In China 04-02-15
Aethlon Medical Discloses Head And Neck Cancer Collaboration 04-02-15
Public Health Agency of Canada Release: Clinical Trials Prove Canada's VSV-EBOV Ebola Vaccine Safe And Effective 04-02-15
Clementia Advances Phase 2 Clinical Trial Of Palovarotene In Fibrodysplasia Ossificans Progressiva Based On Recommendations From Data Monitoring Committee (DMC) 04-02-15
CDC Publishes First National Study On Use Of Behavioral Therapy, Medication And Dietary Supplements For ADHD In Children) 04-02-15
XBiotech Announces Publication Of Positive Clinical Results For Xilonix In Non-Small Cell Lung Cancer 04-02-15
Omeros Corporation Announces The U.S. Commercial Launch Of Omidria 04-02-15
Novartis AG Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs 04-02-15
Pfizer Ceases Vaccine Sales Business in China; 200 Employees Impacted 04-02-15
Roche Ready to Collaborate With Rivals for Cancer Drug Combinations 04-02-15
Botox Biotech Anterios Files For A $58 Million IPO 04-01-15
Takeda Offers $2.2 Billion To Settle Actos Drug Cases 04-01-15
Kala Pharmaceuticals KPI-121 Meets Primary Sign Endpoint In Phase II For Dry Eye Disease 04-01-15
Neurocrine Biosciences, Inc. And Mitsubishi Tanabe Pharma Corporation Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets 04-01-15
CEL-SCI Reports 3rd Consecutive Month Of Record Patient Enrollment In 2015 For Its Phase III Head And Neck Cancer Trial 04-01-15
Kala Pharmaceuticals KPI-121 Meets All Primary Endpoints In Phase 3 For Cataract Surgery 04-01-15
Sysmex America, Inc. Receives For WAM Middleware Solution 04-01-15
Nymox Pharmaceutical Announces Phase 3 BPH Studies 04-01-15
Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 04-01-15
Pharmacyclics Release: Solid Tumor Study Investigating Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Commences In Patients With Relapsed/Refractory Non-Small Cell Lung, Breast And Pancreatic Cancers 04-01-15
Hutchison Medipharma's Cancer Drug Meets Endpoint In Phase II Trial 04-01-15
Anergis Announces Completion Of Treatment In AllerT Phase II Dose-Ranging Trial 04-01-15
Oramed Pharmaceuticals Inc. Enrolls First Patient In Its Glucose Clamp Study For Oral Insulin 04-01-15
Meagan Medical Announces Issuance Of A Key U.S. Patent For A Disruptive Chronic Pain Treatment Using Spinal Cord Stimulation 04-01-15
Pivotal Pharmacokinetic Study Of Innocoll, Inc.'s Xaracoll(R) Supports Use Of 300 Mg Dose For Phase 3 Clinical Studies In Post-Operative Pain 04-01-15
Receptos Completes Enrollment Of RADIANCE Phase 3 Trial Of Ozanimod In Relapsing Multiple Sclerosis 04-01-15
Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy 04-01-15
RegeneRx Biopharmaceuticals, Inc.'s RGN-259 Meets Key Efficacy Objectives In Phase 2 Clinical Trial In Patients With Severe Dry Eye Reported In Current Issue Of Cornea 04-01-15
NIH Funds Study Of Fully Personalized Immunotherapy AGS-004 Combined With A Latency Reversing Therapy For The Treatment Of HIV 04-01-15
Idera Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation For IMO-8400 For The Treatment Of Diffuse Large B-Cell Lymphoma 04-01-15
University of Cincinnati Release: Pulmonary Embolism Risk Scoring Could Guide Treatment, Ease Burden On EDs 04-01-15
Daiichi Sankyo And Asubio Pharma Merge 04-01-15
Karyopharm Appoints Mikael Dolsten, MD, Phd To Its Board Of Directors 04-01-15
Myriad Genetics, Inc. And AstraZeneca PLC Expand Research Collaboration On Lynparza 04-01-15
NeuroDerm Ltd. To Announce Updated Topline Results Of Phase II Study Of Continuous, Subcutaneously-Delivered Levodopa/Carbidopa For The Treatment Of Parkinson's Disease At The 67th Annual Meeting Of The American Academy of Neurology 04-01-15
Immune Design Corporation Announces Positive Topline Data From Three Phase 1 Clinical Trials Of Immuno-Oncology Agents 04-01-15
ESSA Pharma Announces Filing Of Investigational New Drug Application For EPI-506 04-01-15
Merck & Co.'s HPV Vaccine, GARDASIL9, Now Available In Canada 04-01-15
Valeant Completes Tender Offer For Salix 04-01-15
Novavax, Inc. Announces Closing Of Public Offering 04-01-15
Grifols 2014 Annual Report On Form 20-F Filed With The On April 1, 2015 04-01-15
InogenTo File Form 12b-25 With 04-01-15
Why the Flu Vaccine Barely Worked This Year 04-01-15
Mylan N.V. Announces Pricing Of Secondary Public Offering Of A Portion Of Abbott's Ordinary Shares 04-01-15
Vaccinex, Inc. Provides An Update On Its VX15/2503 Phase 1 Clinical Trial In Multiple Sclerosis Patients 03-31-15
Amgen in the Crosshairs As Biogen, Hospira, Merck & Co. All Climb on Biosimilar Bandwagon: Citi 03-31-15
OCuSOFT HypoChlor & The Facts About Hypochlorous Acid 03-31-15
Frost & Sullivan Release: Development And Commercialization Of Antibacterial Drugs To Speed Up 03-31-15
Algal Scientific Secures $7 Million In Funding To Accelerate Its Efforts To Transform The World??'s Food Supply 03-31-15
Teva Wins $170 Million Contract To Make Vaccine In Forest 03-31-15
Cynapsus Therapeutics Announces CAD$21 Million Private Placement 03-31-15
VIVUS, Inc. Updates On Qsymia Plans; Will Continue Talks With U.S., EU Regulators 03-31-15
Syndax Pharmaceuticals Inc. And Merck & Co. To Collaborate On Immuno-Oncology Study Evaluating Entinostat In Combination With KEYTRUDA (Pembrolizumab) In Lung Cancer And Melanoma 03-31-15
Tyrogenex, Inc., Xcovery Appoint As President And Chief Executive Officer 03-31-15
Celladon Corporation Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 03-31-15
Protalex, Inc. Announces FDA Acceptance Of Investigational New Drug Application For PRTX-100 To Treat Immune Thrombocytopenia 03-31-15
Infinity Pharmaceuticals Inc. Shells Out $52.5M to Purchase Cancer Drug Royalties From Takeda 03-31-15
Quintiles, Quest Diagnostics to Combine and Form Global Clinical Trial Lab Joint Venture 03-31-15
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio 03-31-15
BioTie Therapies Corp. Announces Start Of Patient Enrolment Into Phase IIa Clinical Study With BTT1023 In Primary Sclerosing Cholangitis 03-31-15
Trial Shows Stem Cells Provide Long-Term Relief from Dangerous Crohn??'s Side Effect, Reveals 03-31-15
Novartis Pharmaceutical Corporation Announces FDA Approval For Jadenu To Simplify Treatment Administration For Patients With Chronic Iron Overload 03-31-15
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (Rdna Origin)] For Injection And Needle-Free Device In The U.S. 03-31-15
Antares Pharma, Inc. Announces FDA Approval Of TEV-TROPIN(R) 10 Mg (Human Growth Hormone) Needle-Free Injector 03-31-15
BG Medicine Submits 510(K) To FDA For Additional Indication For The BGM Galectin-3(R) Test 03-31-15
PlasmaTech Biopharmaceuticals' Partner Hanmi Pharma Receives Marketing Approval For MuGard In Korea 03-31-15
PAION AG Announces Initiation Of U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Colonoscopy 03-31-15
GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial For Epidiolex In Dravet Syndrome 03-31-15
Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To Treat Heart Failure 03-31-15
RedHill Biopharma Ltd. Acquires Phase II First-in-Class Oral Small Molecule SK2 Inhibitor From 03-31-15
AEterna Zentaris Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina 03-31-15
Biocryst Pharmaceuticals Awarded BCX4430 Advanced Development Contract 03-31-15
ANI Pharmaceuticals, Inc. Announces The Launch Of Propafenone Tablets 03-31-15
Intercept Pharmaceuticals Announces Proposed Offering Of Common Stock 03-31-15
Allen Institute for Brain Science Release: International Initiative Launched To Advance State-Of-The-Art Digital Tracings Of Neurons 03-31-15
Omnicell Announces Conclusion Of Whistleblower Investigation And Filing Of 2014 Annual Report On Form 10-K 03-31-15
Argos Therapeutics, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results 03-31-15
Bellerophon Therapeutics Reports 2014 Full Year Financial And Operational Results 03-31-15
Eli Lilly Announces Date For Diabetes Investor Meeting 03-30-15
SCIEX And Mass Consortium Corporation Announce Exclusive Reseller Agreement Of XCMSplus Metabolomics Software 03-30-15
Janssen Research & Development Release: FDA Approves Label Update For ZYTIGA To Include Statistically Significant Overall Survival Results In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer 03-30-15
Biogen Announces European Medicines Agency Validation Of Marketing Authorization Application For SB2, A Biosimilar Candidate For Infliximab 03-30-15
NovoCure Ltd. Announces Japanese Approval Of Optune (The Novottf-100A System) For Treatment Of Recurrent Glioblastoma 03-30-15
Sorrento Therapeutics, Inc. Announces Appointment Of As EVP & Chief Legal Officer 03-30-15
The Medicines Company Receives European Commission (EC) Approval For Three Hospital Acute Care Products: KENGREXAL (Cangrelor), ORBACTIV (Oritavancin) And RAPLIXA(Sealant Powder) 03-30-15
FDA Grants Amgen Priority Review For Kyprolis (Carfilzomib) Supplemental New Drug Application For The Treatment Of Relapsed Multiple Myeloma 03-30-15
Boehringer Ingelheim Release: Type 2 Diabetes: CHMP Recommends Empagliflozin/Metformin Hydrochloride For Approval In The European Union 03-30-15
Novan Therapeutics Secures $50 Million Private Financing; Funds Intended to Advance SB204 into Phase 3 03-30-15
AstraZeneca PLC Release: BRILINTA Receives FDA Approval For New Administration Option 03-30-15
Cancer Gene Therapy Biotech Files for a $70M IPO 03-30-15
Genzyme??'s Cerdelga (eliglustat) Capsules Approved In Japan 03-30-15
Vaxon Biotech SA Appoints Founder And Chief Scientific Officer, Dr. As CEO 03-30-15
Cardio3 BioSciences Successfully Completes Futility Analysis Of Lead Cardiac Cell Therapy, C-Cure 03-30-15
Can-Fite BioPharma Reports Top-Line Results From Phase II/III Trial For CF101 In Treatment Of Psoriasis 03-30-15
Morphotek Inc. Announces Initiation Of Farletuzumab Study In Patients With First-Relapsed, Platinum-Sensitive Ovarian Cancer With Low Levels Of The Immunosuppressive CA125 Tumor Antigen 03-30-15
Janssen Research & Development Release: New Study Published In JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time To Relapse In Patients With Schizophrenia 03-30-15
Harry Perkins Institute Of Medical Research Release: Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells 03-30-15
CASI Pharmaceuticals Receives Approval From For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 03-30-15
Synageva BioPharma Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Mexico 03-30-15
Adamis Pharmaceuticals Receives Complete Response Letter From FDA For Its Epinephrine Pre-Filled Syringe NDA 03-30-15
Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 03-30-15
Synthetic Biologics, Inc. Initiates Phase 2a Clinical Trial Of SYN-004 To Protect The Microbiome And Prevent C. Difficile 03-30-15
Lion Biotechnologies, Inc. Announces Positive Data From A TIL-Ipilimumab Combination Study In Melanoma 03-30-15
Matinas BioPharma Completes Enrollment In First Human Trial Of MAT9001 03-30-15
PledPharma Presents Top-Line Results From Its Phase Iib Study - Pledox(R) Reduces Nerve Damage In Conjunction With Chemotherapy By 43 Percent 03-30-15
Novavax, Inc. Presents New Data From Non-Human Primate Ebola Challenge At The 03-30-15
DURECT Corporation Announces Initiation Of DUR-928 Multi-Dose Phase 1 Study 03-30-15
BioBlast Pharma Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 03-30-15
FUJIFILM To Acquire Cellular Dynamics 03-30-15
Teva Reinforces Leadership Position In CNS With Acquisition Of Auspex Pharmaceuticals 03-30-15
Horizon Pharma plc. To Acquire Hyperion Therapeutics For $46.00 Per Share Or $1.1 Billion In Cash 03-30-15
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 03-30-15
Columbia Laboratories, Inc. Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 03-30-15
The Biopharmaceutical Business Of Merck KGaA, And Intrexon Corporation Announce Agreement For The Development And Commercialization Of CAR-T Therapy 03-30-15
Valeant Closes Offering Of $1.45 Billion Of Common Shares 03-27-15
Relypsa Presents Sub-Group Analysis From Phase 3 Study Of Patiromer FOS In Patients With Advanced Chronic Kidney Disease At 2015 National Kidney Foundation Spring Clinical Meeting 03-27-15
Applied DNA Sciences, Inc. Prices $11.46 Million Public Offering 03-27-15
SurePure Completes Verification And Approved For Trading On The Marketplace 03-27-15
European Medicines Agency Validates Marketing Authorisation Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment Of MS 03-27-15
Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 03-27-15
Where Were You When Biotech Grew? 03-27-15
European Medicines Agency Release: Accelerated Assessment Fast-Tracks Lenvima To Benefit Patients With Thyroid Cancer 03-27-15
Galderma Announces Positive Outcome Of European Decentralised Procedure For Approval Of Soolantra (Ivermectin) Cream 10mg/G For Rosacea Patients 03-27-15
NephroGenex Announces Data On Acute Kidney Injury At National Kidney Foundation 2015 Spring Clinical Meetings 03-27-15
Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial With Revusiran 03-27-15
NIH Release: Ebola Test Vaccines Appear Safe In Phase 2 Liberian Clinical Trial 03-27-15
NIH Study Finds No Evidence Of Accelerated Ebola Virus Evolution In West Africa 03-27-15
Neogen Corporation Reports 13% Increase In Net Income 03-26-15
GENFIT Corp.'s GFT505 Misses Target in Phase IIB But Hopes to Proceed to Phase III 03-27-15
Ohr Pharmaceutical's OHR-102 Fails in Phase II, Shares Plunge 03-27-15
CoreRx Grabs $7M for Expansion, Plans to Increase Staff By 40% 03-27-15
Novo Nordisk A/S Soars On Plans To Resubmit NDAs Of Tresiba And Ryzodeg In U.S. 03-27-15
Northwest Biotherapeutics Reports Promising Survival Data In 51 Gbm Patients Treated With Dcvax-L 03-27-15
Ohr Pharmaceutical Announces Final Topline Data From OHR-102 Phase II IMPACT Study In Wet-AMD 03-27-15
Proteon Therapeutics, Inc. Announces Positive Long-Term Results From Phase 2 Study Of Investigational New Drug Vonapanitase In Chronic Kidney Disease Patients Undergoing Surgical Creation Of An Arteriovenous Fistula For Hemodialysis 03-27-15
Investigational New Drug Application For WuXi PharmaTech Co., Ltd. MedImmune's Monoclonal Antibody Accepted For Review By 03-27-15
Hospira Clinical Data Shows Proposed Biosimilar, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 03-27-15
RXi Pharmaceuticals And Enter Into An Exclusive Licensing Agreement For s Self-Delivering RNAi (sd-rxRNA) Technology To Develop Cell-Based Immunotherapies To Treat Cancer 03-27-15
Mesoblast Limited Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 03-27-15
Burzynski Research Institute Announces Publication Of Phase 2 Clinical Study In Metastatic Colon Adenocarcinoma Of The Liver 03-27-15
PolyPeptide Group To Manufacture Protected Graft Copolymer (PGC) For PharmaIN 03-27-15
BG Medicine Welcomes Major Publication On The Bioimage Study In The 03-27-15
Johnson & Johnson To Webcast Annual Meeting Of Shareholders 03-27-15
Agile Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 03-27-15
Cara Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 03-27-15
Calithera Biosciences, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Highlights 03-27-15
CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 03-27-15
Heat Biologics Announces Financial Results For The Year Ended December 31, 2014 03-27-15
Synergy Pharmaceuticals May Be for Sale 03-26-15
Orexigen's Mysimba Approved In Europe For The Treatment Of Obesity 03-26-15
Genentech??'s $125M Expansion Brings New Jobs to Hillsboro 03-26-15
MorphoSys AG And Celgene Mutually Agree To End MOR202 Collaboration 03-26-15
Health Canada Greenlights IMRIS Ceiling-Mounted Intraoperative CT Solution 03-26-15
Japan??'s Approves Gilead??'s Sovaldi (Sofosbuvir) For The Treatment Of Genotype 2 Chronic Hepatitis C 03-26-15
Nasdaq Welcomes Cellectis The Nasdaq Stock Market 03-25-15
Redx Pharma To Raise ??15 Million On Stock Market Debut 03-26-15
pSivida Corp Completes Targeted Enrollment Of Phase III Trial Of Medidur For Posterior Uveitis 03-26-15
FSC Laboratories To Market Cefaclor For Oral Suspension In The U.S. 03-26-15
IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 03-26-15
Otonomy, Inc. Initiates Phase 2 Clinical Trial for AuriPro(TM) In Label Expansion Indication 03-26-15
Galena Biopharma Expands Patient Population In NeuVax(TM) (nelipepimut-S) And Trastuzumab Phase 2b Combination Clinical Trial In HER2 1+/2+ Patients 03-26-15
Conatus Pharmaceuticals Inc. Announces Successful Top-Line Results From NAFLD/NASH Clinical Trial Of Emricasan 03-26-15
Aldeyra Therapeutics Opens Enrollment In Noninfectious Anterior Uveitis Phase II Clinical Trial 03-26-15
Apceth GmbH Initiates Phase II Clinical Trial For Pioneering Engineered Cell Therapy To Treat Gastrointestinal Cancer 03-26-15
Transition Therapeutics Inc. Announces Results From Phase 1 AME & Renal Clearance Clinical Studies Of Neuropsychiatric Drug Candidate ELND005 03-26-15
Immune Design Corporation Announces Treatment Of Patients With CMB305 Investigational Immuno-Oncology Agent 03-26-15
BioBlast Pharma Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Mitochondrial Protein Replacement Platform In Friedreich's Ataxia 03-26-15
AlloSource Announces Positive Clinical Results For AlloTrue???-Cleansed And Low-Dose Irradiated Tendons Used In Kaiser Permanente Study Of ACL Revision Risks 03-26-15
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licence Of Anamorelin In China, Hong Kong And Macao 03-26-15
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 03-26-15
Orion Corporation Signs Cooperation Agreement With 03-26-15
CluePoints And ACRES Partner To Improve Data Quality In Clinical Research 03-26-15
Repositive Ltd Raises £300k Seed Funding To Launch Genomic Data Discovery Platform 03-26-15
Emerald Therapeutics Unveils Ecl-1: The First Emerald Cloud Lab Production Facility And Announces First Customers 03-26-15
Creative BioMart Release: Introduction For Native Protein 03-26-15
Reflect Scientific, Inc. Completes Installation Of T-150 Freezers At Major Pharmaceutical Company 03-25-15
Sanofi Pasteur Announces FDA Approval Of Quadracel Dtap-IPV Vaccine For Children 4 Through 6 Years Of Age 03-25-15
Orbis International Receives PR News Award For Branding 03-25-15
Regeneron Release: EYLEA (aflibercept) Injection Receives FDA Approval For The Treatment Of Diabetic Retinopathy In Patients With Diabetic Macular Edema (DME) 03-25-15
Mologen AG: Start Of Pivotal Study For Cancer Immunotherapy MGN1703 Influences 2014 Annual Result 03-25-15
Santen Pharmaceutical Announces Approval Of Ikervis For EU Marketing Authorization 03-25-15
Marinus Pharmaceuticals' Ganaxolone Receives FDA Orphan Drug Designation In PCDH19 Female Epilepsy 03-25-15
Salix Had a $13 Billion Offer on the Table From Allergan Before Accounting Problems Smashed Share Price 03-25-15
Emergent BioSolutions Receives FDA Approval Of Anthrasil, Its Anthrax Immune Globulin, For Use In The Treatment Of Inhalational Anthrax 03-25-15
Lexicon Pharmaceuticals, Inc. Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin 03-25-15
Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study Of MACI Implant 03-25-15
Agios Pharmaceuticals Announces Orphan Drug Designation Of AG-348 For Treatment Of Pyruvate Kinase Deficiency 03-25-15
CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 03-25-15
Lpath, Inc. Reports Results For ASONEP Phase 2a Study In Renal Cell Carcinoma 03-25-15
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm) 03-25-15
Cellular Biomedicine Group Announces Interim Results From Phase IIb Clinical Trial For Knee Osteoarthritis Stem Cell Rejoin Therapy 03-25-15
Cellular Biomedicine Group Announces Phase I Results From CAR-T Immuno-Oncology Clinical Development Programs 03-25-15
Sun Pharma Announces Closure Of Merger Deal With 03-25-15
Lycera Announces Milestone In Merck & Co. Collaboration 03-25-15
Signum Dermalogix Out-Licenses SIG990 To Dermata Therapeutics For Topical Treatment of Rosacea 03-25-15
FDA Approves Genentech's Drug To Treat Children's Growth Disorder 03-24-15
Merck & Co. Study Halted on Positive Phase III Data 03-24-15
Ariad And Medison Pharma Ltd. Announce Approval Of Iclusig (Ponatinib) In Israel 03-24-15
Aerie Pharmaceuticals, Inc. Completes Enrollment In Second Phase 3 Registration Trial (???Rocket 2???) Of Rhopressa, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 03-24-15
La Jolla Pharmaceutical Company Announces Initiation Of Phase III Clinical Trial Of LJPC-501 In Catecholamine-Resistant Hypotension 03-24-15
LFB S.A. Receives Go Ahead From Data Monitoring Committee To Expand The Global PERSEPT Phase 3 Program Of LR769 In Hemophilia A Or B Patients With Inhibitors 03-24-15
Cypher Genomics Releases New Product To Address Major Bottleneck In Personalized Medicine For Cancer 03-24-15
Teikoku Pharma USA Announces New Drug Application To The FDA For Docetaxel Injection Concentrate, Non-Alcohol Formula 03-24-15
MediGene AG Starts Phase I/II Study With DC Vaccine To Treat Acute Myeloid Leukaemia (AML) 03-24-15
EPIRUS Biopharmaceuticals Reports Fourth Quarter And Fiscal Year 2014 Financial Results 03-24-15
BioClinica, Inc. to Open Research Triangle Park Site, Hire Dozens 03-24-15
Lipocine Inc. Announces Results From Pre-NDA Meeting For LPCN 1021, An Oral Testosterone Product Candidate 03-24-15
ThromboGenics NV Announces Positive Topline Results From OASIS Study 03-24-15
Aldeyra Therapeutics Announces First Patient Enrolled In Sjogren-Larsson Syndrome Phase II Clinical Trial 03-24-15
NGM Announces Positive Phase II Clinical Data In Primary Biliary Cirrhosis Patients For NGM282, A First-In-Class Investigational Medicine 03-24-15
Pluristem Therapeutics Announces Key Strategic Objectives For Development Of PLX-R18 In Hematopoietic Indications 03-24-15
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study For Novel Oral Formulations Of Buprenorphine 03-24-15
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 03-24-15
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In /i> 03-24-15
American Academy of Orthopaedic Surgeons Release: Men Have A Higher Level Of Function Before And After Total Knee Replacement Surgery 03-24-15
AvidBiotics Release: Study Published In i> Shows That Avidocin Proteins Prevent Clostridium Difficile Infection In Mice Without Harming Protective Gut Bacteria 03-24-15
American Academy of Orthopaedic Surgeons Release: Diabetes, Previous Joint Pain And Overall Physical Health Predicts Arthritis Pain 03-24-15